Cargando…
Wilms’ Tumor 1-Associated Protein Contributes to Chemo-Resistance to Cisplatin Through the Wnt/β-Catenin Pathway in Endometrial Cancer
BACKGROUND: Cisplatin remains the mainstay of endometrial cancer (EC) chemotherapy. Wilms’ tumor 1-associated protein (WTAP), playing a critical role in transcriptional and post-transcriptional regulation, has been reported as an oncogene, and its expression is elevated in multiple types of human tu...
Autores principales: | Xie, Wenli, Liu, Naifu, Wang, Xiangyu, Wei, Ling, Xie, Wenyan, Sheng, Xiugui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928420/ https://www.ncbi.nlm.nih.gov/pubmed/33680959 http://dx.doi.org/10.3389/fonc.2021.598344 |
Ejemplares similares
-
Tumor Suppressive Role of MUC6 in Wilms Tumor via Autophagy-Dependent β-Catenin Degradation
por: Liu, Bai-Hui, et al.
Publicado: (2022) -
Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway
por: Wang, Xi, et al.
Publicado: (2020) -
Estrogen Receptor 1 Inhibition of Wnt/β-Catenin Signaling Contributes to Sex Differences in Hepatocarcinogenesis
por: Bhat, Mamatha, et al.
Publicado: (2021) -
Ubiquitin C-Terminal Hydrolase L5 (UCHL5) Accelerates the Growth of Endometrial Cancer via Activating the Wnt/β-Catenin Signaling Pathway
por: Liu, Da, et al.
Publicado: (2020) -
Mechanisms of mutant β-catenin in endometrial cancer progression
por: Parrish, Molly L., et al.
Publicado: (2022)